CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Truist Securities Adjusts Price Target on Vericel to $54 From $42, Maintains Buy Rating

Positive
AI Analysis

Summary

Truist Securities raised its price target on Vericel Corporation from $42 to $54 while maintaining a Buy rating.

Importance:3/10
Sentiment:
0.60
analyst_upgradeprice_target_increaserating_maintained
Related Companies

Read the original article

Published by yahoo_finance on July 16, 2026 12:57 PM

Read Original